Jamie Andrew
Chairman @ TRICAPITAL
Melrose, United Kingdom
Jamie Andrew is a funding round investor at TRICAPITAL in Melrose focused on Health Care and Biotechnology. Jamie is a chemical engineer by training, with experience in the mining, oil & gas refining and manufacturing sectors. His previous business interests have included developing products for small marine craft propulsion systems and products for energy generation from water resources. One of his working prototype designs was bought by the BritishScience Museum in 2007 as an example of innovation in maritime technology. Jamie's current business interests cover light engineering, renewable energy (small scale hydro power and biomass), medical devices, retailing and property restoration.Jamie is particularly interested in investing in technology based companies and product innovation. He knows the many pitfalls facing aspiring entrepreneurs and can add real value at board level when it comes to product innovation and commercialisation.Jamie is also an active business director/investor and he holds a number of “independent director” positions within a variety of technology based companies (energy related, medical devices, manufacturing) at chairman and director level (in both the private and voluntary sectors).He has lived in the Borders for more than 20yrs.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Jamie Andrew invests in
Stages Jamie Andrew invests in
Countries Jamie Andrew invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 1 (50%)
- Biotechnology 1 (50%)
- Pharmaceutical 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Aurum Biosciences
|
AURUM Biosciences Ltd develops novel pharmaceuticals for use in a number of different clinical indications of high unmet medical need. Aurum is currently completing preclinical development of ABL101, its lead stroke management product, and envisages initiating clinical studies of efficacy and safety in the near future. Follow-on programmes includeproducts for heart disease, cancer, epilepsy, and dementia. Aurum’s lead project utilises an oxygen carrier and proprietary software for use with MRI in Acute Ischaemic Stroke. Aurum has funding in place to initiate recruitment for a Phase 2 clinical study in stroke patients. | $875.3K / Oct 12, 2020 | |
|
Aurum Biosciences
|
AURUM Biosciences Ltd develops novel pharmaceuticals for use in a number of different clinical indications of high unmet medical need. Aurum is currently completing preclinical development of ABL101, its lead stroke management product, and envisages initiating clinical studies of efficacy and safety in the near future. Follow-on programmes includeproducts for heart disease, cancer, epilepsy, and dementia. Aurum’s lead project utilises an oxygen carrier and proprietary software for use with MRI in Acute Ischaemic Stroke. Aurum has funding in place to initiate recruitment for a Phase 2 clinical study in stroke patients. | $3.9M / Nov 13, 2015 |
Co-Investors
About TRICAPITAL
TRICAPITAL is an experienced business angel syndicate based in Scotland. TRICAPITAL members invest in a portfolio of high potential, high-growth start-ups and innovative companies across Scotland and the north of England.We also work with Scottish Enterprise, Scottish Investment Bank and other angel syndicates to support dynamic companies who area good fit for our members’ investment ambitions.We welcome new investor members, and play an active role in supporting the companies we invest in. UK companies only, with a particular focus on Scotland and the Borders.
TRICAPITAL Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Jamie Andrew
Chairman
|
|||
Andy Purves
Company Secretary & Founder
|
|||
Anthony Foyle
Core Member
|
|||
Douglas Needham
Core Member
|
|||
Gavin Stevenson
Vice Chairman
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Jamie Andrew invest in?
Jamie Andrew invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Funding Round stage. Most of the 2 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Jamie Andrew?
Public channels for Jamie Andrew include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Jamie Andrew last invest?
The most recent investment recorded for Jamie Andrew closed in Oct 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
